pharmaceuticals

A lot of enterprise cybersecurity efforts focus on malicious hackers that work on behalf of larger organizations, be they criminal groups or state actors — and for good reason, since the majorit

While COVID-related stay-at-home orders have been extended in some places, officials in other places in the U.S. have decided to open up. We are watching and waiting to see how this plays out.

Ali Amin-Javaheri grew up in the chemicals business. His father had worked for Iran’s state-owned chemical company and when the family fled the country in the nineteen eighties during the Iran-I

While human travel has become severely restricted in recent months, the movement of goods has remained a constant priority — and in some cases, has become even more urgent. Today, a startup out

BuyMed, a Vietnamese startup that wants to fix Southeast Asia’s complex pharmaceutical distribution networks, announced today it has raised $2.5 million in pre-Series A funding. Investors include Se

Matt Ocko, co-founder of venture firm Data Collective (DCVC), was among a small group of VCs viewed as alarmists when they began tweeting about the coronavirus’s imminent appearance in the U.S.

Food-delivery platforms are on the front lines during the coronavirus crisis, with major spikes in demand as communities are confined at home, likely with more time to cook than usual. And while some

While the aftermath of Super Tuesday has left the Democratic Party riven between its more liberal and moderate wings, investors viewed last night’s results as a win for business and markets. Sha

Toronto-based startup Luna Design and Innovation is a prime example of the kind of space company that is increasingly starting up to take advantage of the changing economics of the larger industry. Fo

Depending on which study you believe, the wearable and digital health market could be worth anywhere from $30 billion to nearly $90 billion in the next six years. If the numbers around the size of the

TruTag Technologies, a company that creates microscopic, edible barcodes to authenticate medications, food, vaping pods and other products, has raised a $7.5 million Series C. The funding, led by Pang

Ginkgo Bioworks is now worth $4 billion after a $290 million capital infusion that will give the company the cash to dramatically expand its developer shop for genetic programming. The Boston-based co

Colorcon, a 58-year-old company that develops, supplies and supports specialty products for the pharmaceutical industry — think food colorants, nutritional coatings, the film on time-release med

Jeff Ubersax knows yeast. The chief executive officer of Demetrix studied yeast genetics and biochemistry in school and was an early employee at Amyris Biotechnologies, a technology company that was u

IBM announced its latest blockchain initiative today. This one is in partnership with KPMG, Merk and Walmart to build a drug supply chain blockchain pilot. These four companies are coming together to

BenevolentAI is an AI company where AI actually means something. Founded in 2013, it focuses on “accelerating the journey from data to medicines.” To achieve that, it has raised a whopping

Biomanufacturing technologies — taking modified versions of existing organisms and bending them to the will of humans — has moved from the world of science fiction to becoming a new realit

The long and litigious saga of Hippo Technologies may finally be over now that the company is finally launching its service to sell discounted prescription drugs to members just three months after set

Scientists interested in cannabis as a subject for pharmaceutical studies may find an unlikely new home for their research into the plant, its byproducts and biochemistry aboard the International Spac

The pace at which the scientific breakthroughs working to bend the machinery of life to the whims of manufacturing have transformed into real businesses has intensified competition in the biomanufactu